Mao Inhibitors + Lacosamide Interaction
Moderateinteraction on record
Description
Strong CYP3A4 inhibitors may significantly increase lacosamide exposure in patients with renal or hepatic impairment. Dose reduction may be necessary.
Mechanism
Inhibition of CYP3A4, a major metabolic pathway for lacosamide
Source: NLP:lacosamide